HIV Clinical Trial
Official title:
PrEP Initiation and Adherence Among Black SMM: A Social Network-Level Intervention
Specific Aim 1. Conduct 18 focus groups among Black gay, bisexual and other sexual minority men (SMM; n=72-90) in the Washington, DC area of different age groups (18-24, 25-34, 35+) and various pre-exposure prophylaxis (PrEP) use profiles (i.e., PrEP naïve, current PrEP users, and discontinued PrEP; two per age-group and PrEP use profile) to understand intervention feasibility, acceptability and appropriateness, how the intervention can address experienced and perceived socio-structural barriers, and increase PrEP initiation and adherence among Black SMM in the Washington, District of Columbia (DC) area. Specific Aim 2. Implement an iterative open-phase pilot of an SNS intervention to increase PrEP initiation among human immunodeficiency virus (HIV)-negative Black SMM, aged 18 years and above, in the Washington, DC area. Recruit 30 PrEP-using Black SMM, including those who use substances, as Recruiters to identify and refer Network Associates to PrEP services. The pilot will occur in six blocks of up to 5 Recruiters to further develop all intervention procedures and enhance the social networking strategy (SNS) intervention's feasibility and acceptability.
Status | Recruiting |
Enrollment | 30 |
Est. completion date | December 2023 |
Est. primary completion date | December 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Age of 18 years or above - Black or African American race - Cisgender male identity - Gay, bisexual or a male who has sex with other males - Residence in the greater Washington, DC area (includes District of Columbia, Prince George's County, MD and Montgomery County, MD) - Current PrEP use - Confirmed HIV-negative status. Exclusion Criteria: - Being younger than 18 years of age ; - Cisgender or transgender female identity - Males having sex with women exclusively - Being unable to speak or read English - Reside outside of the defined greater Washington, DC area - Being unable or unwilling to provide written informed consent - Being unable to comply with the requirements of the protocol (e.g. persons with mental health conditions, persons who are intoxicated or incoherent for other reasons) - Being a member of other vulnerable populations: pregnant women, children or wards of the state. |
Country | Name | City | State |
---|---|---|---|
United States | Us Helping Us, People Into Living, Inc. | Washington | District of Columbia |
Lead Sponsor | Collaborator |
---|---|
Us Helping Us, People Into Living, Inc. |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Feasibility of Intervention as measured by Weiner et al., 2017. | Assess the feasibility of intervention delivery method (i.e., PrEP-using SMM as the Interventionist/Recruiter). | During the peer-based debriefing sessions that occurs before a Recruiter is dismissed from the open-phase pilot. | |
Primary | Acceptability of Intervention as measured by Weiner et al., 2017. | Assess the feasibility of intervention delivery method (i.e., PrEP-using SMM as the Interventionist/Recruiter). | During the peer-based debriefing sessions that occurs before a Recruiter is dismissed from the open-phase pilot. | |
Secondary | Recruited Network Members | Proportion of Recruiters who recruit Network Associates | Immediately after PrEP-using SMM enroll as an Interventionist (i.e., Recruiter) | |
Secondary | Network members on PrEP | Number of Network Associates recruited | Immediately after PrEP-using SMM enroll as an Interventionist (i.e., Recruiter) | |
Secondary | Comfortability of the Intervention as measured by an adaptation of Weiner et al., 2017. | Extent to which Network Associates were comfortable with the intervention modality | During the peer-based debriefing sessions that occurs before a Recruiter is dismissed from the open-phase pilot. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06162897 -
Case Management Dyad
|
N/A | |
Completed |
NCT03999411 -
Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients
|
Phase 4 | |
Completed |
NCT02528773 -
Efficacy of ART to Interrupt HIV Transmission Networks
|
||
Active, not recruiting |
NCT05454839 -
Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
|
||
Recruiting |
NCT05322629 -
Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women
|
N/A | |
Completed |
NCT02579135 -
Reducing HIV Risk Among Adolescents: Evaluating Project HEART
|
N/A | |
Active, not recruiting |
NCT01790373 -
Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence
|
N/A | |
Not yet recruiting |
NCT06044792 -
The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
|
||
Completed |
NCT04039217 -
Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM
|
Phase 4 | |
Active, not recruiting |
NCT04519970 -
Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK)
|
N/A | |
Completed |
NCT04124536 -
Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women
|
N/A | |
Recruiting |
NCT05599581 -
Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health
|
N/A | |
Active, not recruiting |
NCT04588883 -
Strengthening Families Living With HIV in Kenya
|
N/A | |
Completed |
NCT02758093 -
Speed of Processing Training in Adults With HIV
|
N/A | |
Completed |
NCT02500446 -
Dolutegravir Impact on Residual Replication
|
Phase 4 | |
Completed |
NCT03805451 -
Life Steps for PrEP for Youth
|
N/A | |
Active, not recruiting |
NCT03902431 -
Translating the ABCS Into HIV Care
|
N/A | |
Completed |
NCT00729391 -
Women-Focused HIV Prevention in the Western Cape
|
Phase 2/Phase 3 | |
Recruiting |
NCT05736588 -
Elimisha HPV (Human Papillomavirus)
|
N/A | |
Recruiting |
NCT03589040 -
Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant
|
Phase 2 |